全文获取类型
收费全文 | 28534篇 |
免费 | 1567篇 |
国内免费 | 130篇 |
专业分类
耳鼻咽喉 | 420篇 |
儿科学 | 759篇 |
妇产科学 | 550篇 |
基础医学 | 3847篇 |
口腔科学 | 1019篇 |
临床医学 | 2277篇 |
内科学 | 6425篇 |
皮肤病学 | 500篇 |
神经病学 | 2761篇 |
特种医学 | 815篇 |
外国民族医学 | 2篇 |
外科学 | 4188篇 |
综合类 | 147篇 |
一般理论 | 6篇 |
预防医学 | 2328篇 |
眼科学 | 487篇 |
药学 | 1788篇 |
1篇 | |
中国医学 | 90篇 |
肿瘤学 | 1821篇 |
出版年
2024年 | 31篇 |
2023年 | 224篇 |
2022年 | 316篇 |
2021年 | 674篇 |
2020年 | 414篇 |
2019年 | 614篇 |
2018年 | 1055篇 |
2017年 | 700篇 |
2016年 | 757篇 |
2015年 | 946篇 |
2014年 | 1025篇 |
2013年 | 1439篇 |
2012年 | 2368篇 |
2011年 | 2408篇 |
2010年 | 1215篇 |
2009年 | 909篇 |
2008年 | 2062篇 |
2007年 | 2076篇 |
2006年 | 1940篇 |
2005年 | 1833篇 |
2004年 | 1713篇 |
2003年 | 1546篇 |
2002年 | 1366篇 |
2001年 | 266篇 |
2000年 | 260篇 |
1999年 | 224篇 |
1998年 | 129篇 |
1997年 | 93篇 |
1996年 | 84篇 |
1995年 | 80篇 |
1994年 | 53篇 |
1993年 | 64篇 |
1992年 | 117篇 |
1991年 | 106篇 |
1990年 | 95篇 |
1989年 | 84篇 |
1988年 | 54篇 |
1987年 | 57篇 |
1986年 | 59篇 |
1985年 | 68篇 |
1984年 | 73篇 |
1983年 | 59篇 |
1982年 | 67篇 |
1981年 | 43篇 |
1980年 | 51篇 |
1979年 | 42篇 |
1978年 | 33篇 |
1976年 | 37篇 |
1973年 | 34篇 |
1971年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
Jean-Sébastien Fallu Jürgen Rehm Emmanuel N. Kuntsche Esther Grichting Neerav Monga Edward M. Adlaf Susan J Bondy Gerhard Gmel 《Sozial- und Pr?ventivmedizin》2006,8(1):363-372
Volume and profile of alcohol consumption among students and classmates as predictors of aggression and victimization: a multilevel
analysis among Swiss adolescents
Objective:
To test the effects of the volume of alcohol consumption and drinking patterns on alcohol-related aggression and victimization, both at the individual and class levels. 相似文献4.
BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study. 总被引:7,自引:0,他引:7
Marco Medici Joyce Bj van Meurs Fernando Rivadeneira HongYan Zhao Pascal P Arp Albert Hofman Huibert Ap Pols André G Uitterlinden 《Journal of bone and mineral research》2006,21(6):845-854
After reported associations of variations in the BMP-2 gene with osteoporosis in small populations, we studied the association of the BMP-2 gene polymorphisms Ser37Ala and Arg190Ser with osteoporosis in 6353 men and women from the Rotterdam Study. We did not observe an association of these variants with BMD, bone loss, hip structural analysis parameters, and fracture risk. INTRODUCTION: Bone morphogenetic protein 2 (BMP-2) plays a role in osteoblast differentiation. BMP-2 gene variation has previously been associated with osteoporosis in various small populations, but current evidence remains inconclusive about the exact association with osteoporosis. Therefore, we studied the association of two polymorphisms located in the BMP-2 gene (Ser37Ala and Arg190Ser) and haplotypes defined by these polymorphisms with BMD, rates of bone loss, parameters of hip structural analysis (HSA), and fractures in the Rotterdam Study, a large prospective cohort study of diseases in the elderly. MATERIALS AND METHODS: Databases were searched for polymorphisms and haplotype blocks in the BMP-2 gene region. Allele frequencies for Ser37Ala and Arg190Ser were determined in 60 blacks and 110 Chinese from Coriell panels. Genotype data on Ser37Ala and Arg190Ser were available for 6353 individuals from the Rotterdam Study population. Haplotype alleles defined by Ser37Ala and Arg190Ser were inferred using PHASE software. Genotype and haplotype analyses for BMD (measured at the lumbar spine and femoral neck), bone loss per year (measured at the femoral neck), and HSA were performed using AN(C)OVA. Fractures were analyzed using a Cox proportional-hazards model and logistic regression. All outcomes were adjusted for age, height, and weight. RESULTS: Allele frequencies were 2.5% for Ala37 and 40.2% for Ser190, whereas haplotype allele frequencies were 57.28% (Ser37Arg190), 40.19% (Ser37Ser190), 2.50% (Ala37Arg190), and 0.02% (Ala37Ser190). For BMD, bone loss, HSA outcomes, and (incident) fractures, no differences could be seen between genotype and haplotype groups. Conclusions: In this large population-based cohort of Dutch whites, we conclude that the BMP-2 Ser37Ala and Arg190Ser polymorphisms or haplotypes thereof are not associated with parameters of osteoporosis. 相似文献
5.
6.
7.
8.
9.
10.
Emmanuel J Favaloro Roslyn Bonar Elizabeth Duncan Susan Rodgers Katherine Marsden 《Blood coagulation & fibrinolysis》2007,18(5):441-448
The PFA-100 is a relatively new laboratory instrument, first described in 1995. There have since been numerous studies assessing its utility as a screening tool for platelet dysfunction and/or von Willebrand's disease (VWD). The PFA-100 displays variable sensitivity to different types of platelet disorders, as well as to antiplatelet medication (e.g. aspirin), with similar caveats for monitoring of primary haemostasis-promoting therapies in platelet dysfunction. There is therefore considerable uncertainty regarding its utility within this context, and we have accordingly performed an audit of usage among participants of the Royal College of Pathologists of Australasia Quality Assurance Program. Of 105 laboratories surveyed, 40 responded that they performed platelet function testing, with 26 (65%) further indicating they utilized the PFA-100. We report a wide variety of laboratory usage among these users, including numbers of tests performed [annual median (range) = 270 (15-6000)], sources of requests (clinical sources and localities), testing criteria and follow-up action. Most tests were completed within 4 h of collection, as recommended by the manufacturer, and most tests were performed as a replacement, or as a preliminary screen of platelet function (i.e. classical aggregation). Most abnormal findings, however, were attributed to antiplatelet medication such as aspirin. 相似文献